DKS Co Ltd

Chart & Performance

D1W1MN

P/E

28.06

P/S

0.52

EPS

122.60

Div Yield, %

1.74%

Shrs. gr., 5y

-1.19%

Rev. gr., 5y

1.16%

Revenues

63.12b

-3.02%

Net income

1.17b

CFO

7.09b

+879.42%

Dividend

Mar 28, 20250 JPY/sh

Profile

DKS Co. Ltd. produces and sells surfactants and other industrial chemicals for various industries in Japan and internationally. It operates through six segments: Surfactants, Amenity Materials, Polyurethane Materials, Functional Materials, Electronic Device Materials, and Life Sciences. The company offers nonionic, anionic, cationic, polymerizable, and amphoteric surfactants, as well as formulated surfactant blends; and amenity materials, including sucrose fatty acid esters, sodium carboxymethyl celluloses, cellulose nanofibers and polymers, polyvinyl pyrrolidone, polyacrylamide and polyacrylate, industrial deodorants, and other products. It also provides polyurethane materials, such as polyether polyol, urethane prepolymer, and urethane systems; functional materials comprising radiation-curable monomers and oligomers, waterborne polyurethanes, flame retardants, and amide-based lubricants; and electronic device materials that include ionic liquids, ion-conductive polymers, and ceramic/metal injection molding materials, as well as conductive pastes for electronics, injection molding pellets, and functional inorganic materials. Further, the company supplies health food products that include an I. Japonica-Bombyx Fungus dietary supplement; and Sudachin, a peel extract powder made from citrus fruit. DKS Co. Ltd was formerly known as Dai-ichi Kogyo Seiyaku Co., Ltd. and changed its name to DKS Co. Ltd. in 2013. The company was founded in 1909 and is headquartered in Kyoto, Japan.

URL

https://www.dks-web.co.jp/

IPO date

May 16, 1949

Employees

1,104

Domiciled in

Incorporated in

Valuation

Order:

Title JPY in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title JPY in thousands, except ratios and share amounts	2024‑03	2023‑03	2022‑03	2021‑03	2020‑03	2019‑03	2018‑03	2017‑03	2016‑03	2015‑03
Income
Revenues	63,118,000 -3.02%	65,081,000 3.84%	62,672,000 5.97%
Cost of revenue	61,040,000	67,128,000	60,991,000
Unusual Expense (Income)
NOPBT	2,078,000	(2,047,000)	1,681,000
NOPBT Margin	3.29%		2.68%
Operating Taxes	700,000	274,000	1,139,000
Tax Rate	33.69%		67.76%
NOPAT	1,378,000	(2,321,000)	542,000
Net income	1,174,000 -388.45%	(407,000) -116.33%	2,492,000 -2.77%
Dividends	(573,000)	(840,000)	(712,000)
Dividend yield	1.63%	4.58%	2.53%
Proceeds from repurchase of equity		(1,500,000)
BB yield		8.17%
Debt
Debt current	8,363,000	6,990,000	7,269,000
Long-term debt	29,112,000	28,084,000	26,711,000
Deferred revenue	5,000	153,000	181,000
Other long-term liabilities	430,000	263,000	260,000
Net debt	15,699,000	19,730,000	15,986,000
Cash flow
Cash from operating activities	7,091,000	724,000	5,520,000
CAPEX	(2,502,000)	(2,834,000)	(2,661,000)
Cash from investing activities	(2,008,000)	(2,883,000)	(2,700,000)
Cash from financing activities	1,646,000	(1,030,000)	(2,336,000)
FCF	2,238,000	(3,490,000)	(725,000)
Balance
Cash	16,126,000	9,128,000	12,224,000
Long term investments	5,650,000	6,216,000	5,770,000
Excess cash	18,620,100	12,089,950	14,860,400
Stockholders' equity	36,490,000	66,440,000	69,775,000
Invested Capital	58,240,900	57,820,050	56,216,600
ROIC	2.37%		0.98%
ROCE	2.67%		2.35%
EV
Common stock shares outstanding	9,566	9,737	10,181
Price	3,670.00 94.69%	1,885.00 -31.68%	2,759.00 -25.03%
Market cap	35,107,220 91.28%	18,354,245 -34.66%	28,089,379 -24.98%
EV	55,355,220	74,967,245	83,342,379
EBITDA	5,294,000	1,461,000	5,261,000
EV/EBITDA	10.46	51.31	15.84
Interest	295,000	236,000	225,000
Interest/NOPBT	14.20%		13.38%